We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Flow Cytometer Platform Improves High Throughput Screening

By LabMedica International staff writers
Posted on 17 May 2010
A fully automated platform has been introduced that combines cell-based screening and high throughput flow cytometry and efficiently incorporates analysis capabilities. More...
Potential applications include antibody screening, cytotoxicity studies, and biomarker analysis.

Flow cytometry (FC) is a technique for counting and examining cell suspensions by an electronic detection apparatus. This is one of the most sensitive methods for identifying fluorescent markers on cells and has now been integrated with proprietary technology and an advanced server-based informatics platform.

High Throughput Flow Cytometry (HTFC) Screening System uses HyperCyt, an automated sampler that transfers cells from microplate wells to the flow cytometer by means of peristaltic pump. The series of cells and air gaps are introduced into the cytometer in a highly controlled fashion. The data from each plate is stored in a single file and analyzed using HyperCytPRO, an advanced server based informatics platform. The simple, yet powerful apparatus allows for cost effective screening of more compounds, a broad range of experiments and analysis of complex data.

The HTFC screening system is produced by IntelliCyt Corporation (Albuquerque, NM, USA), which provides cell and bead-based screening products for life sciences and the pharmaceutical industry. The HTFC system can be used to differentiate cell populations or multiplexed bead suspensions from either 96-well or 384-well microplates at a rate of 40 wells per minute. A significant reduction in overall costs can be made as the apparatus can accommodate very small samples and minimal quantities of reagents.

R. Terry Dunlay, IntelliCyt president and CEO said, "By coupling our high-throughput sampler with the large dynamic range and multiplexing capability of flow cytometry-based detectors, the HTFC Screening System provides scientists with powerful advantages over other currently available technologies."

Related Links:
IntelliCyt Corporation



New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
New
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.